Status | Study |
Not yet recruiting |
Study Name: Predicting Visceral Leishmaniasis in HIV Infected Patients Condition: Leishmaniasis, Visceral Date: 2017-01-05 Interventions: Other: No intervention No intervention |
Recruiting |
Study Name: The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil Condition: Leishmaniasis Date: 2015-08-19 Interventions: Drug: Meglumine antimoniate 20 |
Recruiting |
Study Name: Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Condition: Mucocutaneous Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine |
Recruiting |
Study Name: Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Condition: Mucocutaneous Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine |
Recruiting |
Study Name: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Condition: Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days |
Completed |
Study Name: Liposomal Amphotericin in Disseminated Leishmaniasis Condition: Disseminated Leishmaniasis Date: 2013-12-26 Interventions: Drug: Liposomal Amphotericin B Liposomal Amphotericin B will be administered by intravenous route, 3 to |
Not yet recruiting |
Study Name: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condition: Visceral Leishmaniasis Date: 2012-03-27 Interventions: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
Completed |
Study Name: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2011-10-24 Interventions: Drug: Meglumine antimonate Glu |
Completed |
Study Name: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis Condition: Leishmaniasis Leishmaniasis, Mucoc Date: 2011-06-20 Interventions: Drug: Miltefosine 1 Capsule of |
Terminated |
Study Name: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condition: Visceral Leishmaniasis Date: 2011-03-07 Interventions: Drug: Antimoniate of N-methylglucamine |